June 08, 2026
9 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Evidence suggests inflammatory bowel disease is equally prevalent in transgender and cisgender populations. However, it remains unclear whether gender-affirming care and the higher rates of trauma experienced by many transgender patients affect disease course.As political pressure threatens access to gender-affirming hormone therapy (GAHT), patients with IBD who are transgender are increasingly
June 08, 2026
9 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses lingering questions on the potential risks that gender-affirming…

LAS VEGAS — LGBTQ+ individuals with inflammatory bowel disease experience multiple gaps and inequities in care when managing…

Clinicians should carefully monitor patients with inflammatory bowel disease and comorbid Clostridioides difficile infection,…

CHICAGO — In this video, Chandler S. Cortina, MD, MS, FACS, discusses a cohort study that highlights the importance of additional…

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid and…

The HLA-DRB1*01:03 allele was associated with severe outcomes across inflammatory bowel disease subtypes, including perianal…